Altimmune Inc (ALT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2008 | 12-2007 | 09-2007 | 06-2007 | 03-2007 | |
| Sales | 5,840 | 5,963 | 3,372 | 2,339 | 2,969 |
| Gross Profit | 5,840 | 5,963 | 3,372 | 2,339 | 2,969 |
| Operating Expenses | 10,483 | 11,289 | 7,008 | 7,132 | 5,719 |
| Operating Income | -4,643 | -5,326 | -3,636 | -4,793 | -2,750 |
| Interest Expense | 667 | 758 | 594 | 530 | 242 |
| Other Income | 561 | 984 | 3,913 | 79 | 63 |
| Pre-tax Income | -4,749 | -5,099 | -317 | -5,243 | -2,928 |
| Net Income Continuous | -4,749 | -5,099 | -317 | -5,243 | -2,928 |
| Net Income | $-4,749 | $-5,099 | $-317 | $-5,243 | $-2,928 |
| EPS Basic Total Ops | -66.07 | 5,087.09 | -21.02 | -3,378.38 | -2,252.25 |
| EPS Basic Continuous Ops | -64.57 | 3,524.63 | -6.72 | -2,533.92 | -1,416.07 |
| EPS Diluted Total Ops | -66.07 | 5,087.09 | -21.02 | -3,378.38 | -2,252.25 |
| EPS Diluted Continuous Ops | -64.57 | 3,524.63 | -6.72 | -2,533.92 | -1,416.07 |
| EBITDA(a) | $-4,439 | $-5,193 | $-3,423 | $-4,630 | $-2,603 |